Recent News

Vudalimab for the Treatment of Mesothelioma

May 27, 2022

The MD Anderson Cancer Center is conducting a study on an immunotherapy drug that is specifically for rare, advanced tumors. Pleural and peritoneal mesothelioma are both included in the study.[…]

Proton Beam Radiation Therapy Use Increases for Mesothelioma and Lung Cancer

May 20, 2022

Proton beam radiation therapy is growing in popularity for treating mesothelioma and lung cancer. A study in JAMA Oncology looked at the use of this radiation for treating different types[…]

Monoclonal Antibody Treatment was Found Not to be Effective on Pleural Mesothelioma

May 13, 2022

A phase II clinical trial comparing anetumab ravtansine to the chemotherapy drug vinorelbine did not have promising results for treating mesothelioma like researchers had hoped. Anetumab ravtansine is an immunotherapy[…]

High HITHOC Dosage for Pleural Mesothelioma Improves Survival

May 6, 2022

High doses of hyperthermic intrathoracic chemotherapy (HITHOC) help pleural mesothelioma patients. A recent study found that when HITHOC is administered at a high dose, survival rates improve and periods of[…]

Two Cytoreductive Surgeries Can Improve Survival for Peritoneal Mesothelioma Patients

April 29, 2022

If peritoneal mesothelioma patients undergo a second surgery after recurrence, they can improve their survival. Data from a retrospective review from Wake Forest Baptist Medical Center shows that cytoreductive surgery[…]

Checkmate 743 Shows Immunotherapy is Better for Mesothelioma Patients Who Cannot Receive Surgery

April 22, 2022

A clinical trial called Checkmate 743, which looks at the immunotherapy drugs nivolumab (Opdivo) and ipilimumab (Yervoy), shows that the combination can create a better quality of life when compared[…]

A Full Ban on Asbestos Was Recently Proposed

April 14, 2022

The Environmental Protection Agency just proposed a ban of all uses of chrysotile asbestos. It is the only asbestos that is imported into the country today. If banned, the material[…]

Platelet Count Can Potentially Influence Mesothelioma Survival

April 8, 2022

Mesothelioma is a hard-to-treat cancer. Usually chemotherapy, surgery, radiotherapy, and immunotherapy are used, but they do not do enough to save people’s lives. Scientists may have figured out why this[…]

A Cancer Vaccine Could Potentially Help Mesothelioma Patients

April 1, 2022

Researchers are looking at a vaccine to maintain patient health after cancer treatment, which could be effective for mesothelioma in the future.  The vaccine is specifically made for each patient[…]

Researchers are Targeting Fibrosis to Improve Mesothelioma Care

March 25, 2022

Researchers have found that targeting lung fibrosis can help people with mesothelioma. People with mesothelioma usually suffer from fibrosis, which is the stiffening of tissue surrounding tumors. Certain drugs to[…]

Skip to content